Portfolio company OncoHost received the Gold Award at the 2025 Merit Awards for Business in Research & Development.
OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes through its PROphet® platform, which uses bioinformatic proteomic pattern recognition and AI to generate personalized scores predicting the benefit of PD-1/PD-L1 inhibitors in oncology
OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes through its PROphet® platform, which uses bioinformatic proteomic pattern recognition and AI to generate personalized scores predicting the benefit of PD-1/PD-L1 inhibitors in oncology.